Dr Reddys Laboratories (RDY) Retained Earnings (2010 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Retained Earnings of $42.0 million for Q1 2026, down 98.86% year-over-year from $3.7 billion in Q1 2025, and down 98.86% quarter-over-quarter from $3.7 billion in Q1 2025.
Dr Reddys Laboratories (RDY) Retained Earnings (2010 - 2026) Analysis & Trends
Dr Reddys Laboratories' Retained Earnings history runs 10 years deep, the most recent figure standing at $42.0 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 98.86% year-over-year to $42.0 million; the TTM figure through Mar 2026 stood at $42.0 million (down 98.86% YoY), while the FY2026 annual figure was $42.0 million, down 98.86% from the prior year.
- Retained Earnings for Q1 2026 stood at $42.0 million, down from $3.7 billion in the prior quarter.
- The five-year high for Retained Earnings was $3.7 billion in Q1 2025, with the low at $28.0 million in Q1 2024.
- The 5-year median for Retained Earnings is $45.0 million (2022), against an average of $1.3 billion.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings plunged 98.93% in 2024, then jumped 13103.57% in 2025.
- Dr Reddys Laboratories' Retained Earnings stood at $45.0 million in 2022, then soared by 5728.89% to $2.6 billion in 2023, then slumped by 98.93% to $28.0 million in 2024, then surged by 13103.57% to $3.7 billion in 2025, then sank by 98.86% to $42.0 million in 2026.
- Business Quant data shows RDY's Retained Earnings at $42.0 million in Q1 2026, $3.7 billion in Q1 2025, and $28.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | -800.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.00 Mn |
| Mar 31, 2025 | 3.70 Bn |
| Mar 31, 2024 | 28.00 Mn |
| Mar 31, 2023 | 2.62 Bn |
| Mar 31, 2022 | 45.00 Mn |
| Mar 31, 2021 | 87.00 Mn |
| Mar 31, 2020 | 13.00 Mn |
| Mar 31, 2019 | 1.86 Bn |
| Mar 31, 2018 | 1.75 Bn |
| Sep 30, 2010 | 1.02 Bn |
| Jun 30, 2010 | 1.01 Bn |
| Mar 31, 2010 | 925.00 Mn |